Clinical Trials | March 09, 2022
SRL Diagnostics report indicates women neglect routine tests
Routine tests undertaken by women dropped by 35% in 2020
Routine tests undertaken by women dropped by 35% in 2020
New results build on previously reported significant recurrence-free survival (rfs) benefit seen in these patients
Women's health is in fact a direct reflection of the nation's overall health
Dr. Bibikova is an international leader with over 25 years of experience in genomics industry
The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe
WuXi STA’s drug product site in Wuxi City offers a full range of services including formulation development and manufacturing for a broad range of oral and injectable dosage forms
Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer
Large players are adequately capitalised to make bigger investments to adjust for the ongoing fundamental shift in market opportunities
Allogeneic discogenic cell therapy was well tolerated and produced clinically meaningful, statistically significant improvements in low back pain, function, and quality of life by 12 weeks following intradiscal injection
Study to evaluate effectiveness of hypoglossal nerve stimulation
Subscribe To Our Newsletter & Stay Updated
